Activation of Prostaglandin FP and EP2 Receptors Differently Modulates Myofibroblast Transition in a Model of Adult Primary Human Trabecular Meshwork Cells
Autor: | Stéphane Mélik-Parsadaniantz, Michael Bakria, Thomas Debeir, William Rostène, Fanny Beguier, Caroline Leriche, Xavier Vigé, Georges Kalouche, Christophe Baudouin |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Adult Male Prostaglandins E Synthetic medicine.medical_specialty Myosin light-chain kinase Myosin Light Chains genetic structures Cell Survival Prostaglandin E2 receptor Blotting Western Receptors Prostaglandin Prostaglandin macromolecular substances Dinoprost Real-Time Polymerase Chain Reaction 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Trabecular Meshwork Internal medicine medicine Animals Humans Alprostadil Receptor Myofibroblasts Actin Antihypertensive Agents Cells Cultured Glaucoma Receptors Prostaglandin E EP2 Subtype Immunohistochemistry Actins Cell biology Rats 030104 developmental biology Endocrinology medicine.anatomical_structure Neuroprotective Agents chemistry Prostaglandins F Synthetic 030221 ophthalmology & optometry Latanoprost RNA Trabecular meshwork Signal transduction Myofibroblast Signal Transduction |
Zdroj: | Investigative ophthalmologyvisual science. 57(4) |
ISSN: | 1552-5783 |
Popis: | Purpose Prostaglandin F2α analogues are the first-line medication for the treatment of ocular hypertension (OHT), and prostanoid EP2 receptor agonists are under clinical development for this indication. The goal of this study was to investigate the effects of F prostanoid (FP) and EP2 receptor activation on the myofibroblast transition of primary trabecular meshwork (TM) cells, which could be a causal mechanism of TM dysfunction in glaucoma. Methods Human primary TM cells were treated with either latanoprost or butaprost and TGF-β2. Trabecular meshwork contraction was measured in a three-dimensional (3D) TM cell-populated collagen gel (CPCG) model. Expression of α-smooth muscle actin (α-SMA) and phosphorylation of myosin light chain (MLC) were determined by Western blot. Assembly of actin stress fibers and collagen deposition were evaluated by immunocytochemistry. Involvement of p38, extracellular signal-regulated kinase (ERK), and Rho-associated kinase (ROCK) pathways as well as matrix metalloproteinase activation was tested with specific inhibitors. Results In one source of validated adult TM cells, latanoprost induced cell contraction as observed by CPCG surface reduction and increased actin polymerization, α-SMA expression, and MLC phosphorylation, whereas butaprost inhibited TGF-β2-induced CPCG contraction, actin polymerization, and MLC phosphorylation. Both agonists inhibited TGF-β2-dependent collagen deposition. The latanoprost effects were mediated by p38 pathway. Conclusions Latanoprost decreased TM collagen accumulation but promoted a contractile phenotype in a source of adult TM cells that could modulate the conventional outflow pathway. In contrast, butaprost attenuated both TM contraction and collagen deposition induced by TGF-β2, thereby inhibiting myofibroblast transition of TM cells. These results open new perspectives for the management of OHT. |
Databáze: | OpenAIRE |
Externí odkaz: |